Sign-up   Forgot your password?
Home Page  Türkçe  Contact  

       [ ]


Apr 1, 2016

EMA launched PRIME..

This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.

Through PRIME, the Agency offers early and proactive support to medicine developers to optimise the generation of robust data on a medicine’s benefits and risks and enable accelerated assessment of medicines applications.

This will help patients to benefit as early as possible from therapies that may significantly improve their quality of life.


« Back

Clinical Research Association © 2006-2007 PLEKSUS